BENZOTHIENO [3,2-c]PYRAZOLYL AND BENZOFURANO [3,2-c] PYRAZOLYL COMPOUNDS, THEIR USE IN DISEASES ASSOCIATED WITH THE 5-HT2C RECEPTOR AND INTERMEDIATE COMPOUNDS THEREOF

Disclosed are benzothieno[3,2-c]pyrazolyl and benzofurano[3,2-c]pyrazolyl compounds of the formula (I) and (II), and intermediates of the formula (Ia) and (IIa) which are tautomers, wherein the variables A, X, y, R1, R2, R3 and R4 are as defined in the specification. The compounds are useful for the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	CHOI, SOONGYOU, LADOUCEUR, GAETAN, H, WANG, YAMIN
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Disclosed are benzothieno[3,2-c]pyrazolyl and benzofurano[3,2-c]pyrazolyl compounds of the formula (I) and (II), and intermediates of the formula (Ia) and (IIa) which are tautomers, wherein the variables A, X, y, R1, R2, R3 and R4 are as defined in the specification. The compounds are useful for the treatment or prevention of diseases and/or behaviors involving the 5-HT2C receptor site. L'invention concerne des composés de benzothiéno[3,2-c]pyrazolyl et benzofurano[3,2-c]pyrazolyl des formules (I) et (II) et des intermédiaires des formules (Ia) et (IIa) qui sont des tautomères, dans lesquelles les variables A, X, y, R1, R2, R3 et R4 sont telles que définies dans le descriptif. Les composés servent dans le traitement ou la prévention de maladies et/ou de comportements impliquant le site récepteur 5-HT2C.